secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytomX Therapeutics, Inc. (CTMX)
CIK:        0001501989
Form:       8-K
Filed at:   2025-02-26T23:59:59+00:00
Accession:  0001193125-25-036794
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

CytomX receives Nasdaq delisting notice for bid price non-compliance
--------------------------------------------------------------------

- Nasdaq notified CytomX on Feb 24, 2025 that common stock bid price stayed below $1.00 for 30 consecutive business days through Feb 21, 2025.
- Company has 180 calendar days, until August 25, 2025, to regain compliance by closing at $1.00 for 10 consecutive business days.
- If not cured by the deadline, CytomX may transfer to Nasdaq Capital Market for an additional 180-day compliance period.
- Company will monitor bid price and consider options, but there is no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501989/000119312525036794/0001193125-25-036794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501989/000119312525036794/d891467d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-036794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer